Title : Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.

Pub. Date : 1991 Jul

PMID : 1718682






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The long-acting beta 2-agonists, including formoterol, represent a significant advance over current maintenance or prophylactic bronchodilator therapy with intermediate-acting beta 2-agonists such as salbutamol, fenoterol and terbutaline, predominantly because of the twice daily administration regimen. Terbutaline potassium calcium-activated channel subfamily M regulatory beta subunit 2 Homo sapiens